Agouron Pharmaceuticals Gets AIDS Research Grant

Agouron Pharmaceuticals Inc. of La Jolla, in collaboration with Cambridge BioScience Corp., has received a $4.3-million grant from the National Institutes of Health to develop therapeutic drugs, vaccines and diagnostics against the AIDS virus. William Haseltine of the Dana-Farber Cancer Institute at Harvard University will also participate in the research program.

Under terms of the agreement, Agouron will have the right to commercialize therapeutic drugs developed through the collaboration, and Cambridge BioScience will have rights to the vaccines and diagnostics.